Skip to main content
. 2015 Aug 22;6(10):1011–1019. doi: 10.7150/jca.12738

Figure 1.

Figure 1

Figure 1

SR-T100 treatment increases cell sensitivity to cisplatin and paclitaxel. Cell viability following SR-T100 (A), cisplatin (B), or combined (C) treatment was measured by MTT assay. (D) Cell viability following combination treatment with SR-T100 and cisplatin or paclitaxel was measured by MTT assay. All experiments were performed in triplicate.